{"id": "fh97hz", "title": "BMY April Calls", "selftext": "[https://www.google.com/amp/s/seekingalpha.com/amp/article/4330874-coronavirus-fears-make-bristol-myers-squibb-buy](https://www.google.com/amp/s/seekingalpha.com/amp/article/4330874-coronavirus-fears-make-bristol-myers-squibb-buy)\n\n\"In summary, Bristol-Myers Squibb is a more powerful pharmaceutical firm with the Celgene acquisition, with a wide variety of profitable treatments, a strong balance sheet, and a sustainable dividend. And due to ongoing concerns about the coronavirus epidemic, it is now trading at an 18% discount to fair value and offering a 2.98% dividend yield. The stock is a buy at this time.\"\n\nTldr: \"fair value of $71.01\"\n\n$70c 4/30", "created_utc": 1583980051.0, "permalink": "/r/wallstreetbets/comments/fh97hz/bmy_april_calls/", "is_self": true}